Travel-Related Infections

Travel-related infections remain a major global health concern as international travel, migration, and globalization continue to increase the risk of cross-border transmission of infectious diseases. Travelers may be exposed to vector-borne, foodborne, waterborne, and respiratory pathogens, making pre-travel risk assessment, vaccination, surveillance, and early diagnosis essential for disease prevention. This track focuses on the latest advances in travel medicine, emerging travel-associated infections, outbreak surveillance, diagnostics, vaccination strategies, and global health policies aimed at protecting travelers and preventing international disease spread.

Market Analysis: The global travel-related infection prevention, diagnostics, and therapeutics market is estimated to be valued at USD 4.1 billion in 2025 and is projected to reach approximately USD 6.9 billion by 2030, growing at a CAGR of 10.8% during the forecast period. Market growth is driven by increasing international travel, rising awareness of travel-associated infectious diseases, expanding vaccination and pre-travel health services, and advancements in rapid diagnostics. North America and Europe continue to lead the market due to well-established travel medicine programs, while the Asia-Pacific and Latin America regions are expected to witness the fastest growth, supported by increasing outbound tourism, healthcare investments, and strengthened infectious disease surveillance systems.

ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance

Tags
Influenza Conferences Infectious Diseases Conferences Infectious Disease Conferences 2026 Asia Pathology Conferences Epidemiology Conferences HIV/AIDS Conferences Vector-Borne Diseases Conferences Contagious Diseases Conferences Infectious Diseases Conferences Europe Entomology Conferences Infection Conferences 2026 Parasitology Conferences Bacteriology Conferences Infection Control Conferences Infection Conferences 2026 USA

+1 (506) 909-0537